You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MCD

Showing 1 - 25 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Focal Segmental Glomerulosclerosis and Minimal Change Disease

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • +3 more
  • Biospecimen collection
  • Data collection
  • Ann Arbor, Michigan
    University of Michigan
Dec 6, 2022

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Shanghai (Orelabrutinib + R-CHOP, Placebo + R-CHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Orelabrutinib + R-CHOP
  • Placebo + R-CHOP
  • Shanghai, Shanghai, China
    Shanghai Ruijing Hospital
Nov 28, 2022

Minimal Change Disease, Focal Segmental Glomerulosclerosis Trial in United States (VB119)

Recruiting
  • Minimal Change Disease
  • Focal Segmental Glomerulosclerosis
  • Los Angeles, California
  • +7 more
Jul 19, 2022

NEPTUNE Match Study

Enrolling by invitation
  • Nephrotic Syndrome in Children
  • +7 more
  • Communication
  • Atlanta, Georgia
  • +15 more
Jan 30, 2023

FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

Recruiting
  • FSGS
  • +3 more
  • Ann Arbor, Michigan
  • +3 more
Jan 31, 2022

Understand Genetics and Clinical Course of Focal Segmental

Terminated
  • Glomerulosclerosis, Focal Segmental
  • +2 more
  • FSGS/TR-MCD
  • Diabetic Nephropathy (DN)
  • Mesa, Arizona
  • +17 more
Jul 17, 2021

Sensor in Elderly People's House Living Alone (Fragility Box)

Completed
  • Aging
  • Focus groups
  • Individual interviews
  • Saint-Étienne, France
    Gérontopole AURA
Feb 17, 2021

KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

Not yet recruiting
  • KSHV Inflammatory Cytokine Syndrome (KICS)
  • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 2, 2023

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

Recruiting
  • Glomerulonephritis
    • Shanghai, China
    • +4 more
    Feb 27, 2023

    Multicentric Castleman Disease Trial in Beijing (Thalidomide, cyclophosphamide and prednisone)

    Unknown status
    Has Results
    • Multicentric Castleman Disease
    • Thalidomide, cyclophosphamide and prednisone
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 5, 2020

    Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

    Recruiting
    • Multicentric Castleman Disease
    • Lilongwe, Malawi
      UNC Project, Kamuzu Central Hospital
    May 2, 2022

    Nephrotic Syndrome Study Network

    Recruiting
    • Minimal Change Disease (MCD)
    • +2 more
    • Kidney Biopsy
    • Los Angeles, California
    • +34 more
    Jan 3, 2022

    Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

    Active, not recruiting
    • Lymphoproliferative Disorder
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Orelabrutinib in Combination With Standard Treatment Regimen for

    Not yet recruiting
    • Lymphoma, Large B-Cell, Diffuse Neoplasms by Histologic Type
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Aug 23, 2023

    Kidney Disease Trial run by the NIDDK (N-acetyl D-mannosamine)

    Completed
    • Kidney Disease
    • N-acetyl D-mannosamine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

    Completed
    • SARS-CoV Infection
    • +3 more
    • Moderna COVID-19 Vaccine
    • +2 more
    • Tucson, Arizona
    • +28 more
    Sep 19, 2022

    Kidney Diseases, Diabetic Nephropathies, Glomerulosclerosis, Focal Segmental Trial in United States (GFB-887, Placebo)

    Recruiting
    • Kidney Diseases
    • +10 more
    • Birmingham, Alabama
    • +75 more
    Mar 29, 2022

    Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease Trial in United States (Abatacept, Normal Saline,

    Completed
    Has Results
    • Nephrotic Syndrome
    • +2 more
    • Birmingham, Alabama
    • +26 more
    Feb 10, 2021

    Nephrotic Syndrome Trial in Ranica (Blood sampling)

    Recruiting
    • Nephrotic Syndrome
    • Blood sampling
    • Ranica, BG, Italy
      Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
    Jan 25, 2023

    Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome Trial in Cologne (Biosampling)

    Recruiting
    • Glomerulosclerosis, Focal Segmental
    • +2 more
    • Biosampling
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Nov 12, 2021

    Periodontitis, Peri-implant Mucositis, Peri-Implantitis Trial in Kuala Lumpur (Megagen implant placement, Biomate-Swiss implant)

    Recruiting
    • Periodontitis
    • +2 more
    • Megagen implant placement
    • Biomate-Swiss implant
    • Kuala Lumpur, Wilayah Persekutuan, Malaysia
      Faculty of Dentistry, University of Malaya
    Apr 17, 2023

    Focal Segmental Glomerulosclerosis, Minimal Change Disease, Immunoglobulin A Nephropathy Trial in Worldwide (Sparsentan)

    Recruiting
    • Focal Segmental Glomerulosclerosis
    • +4 more
    • Wilmington, Delaware
    • +32 more
    Jan 10, 2023

    Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

    Not yet recruiting
    • Diffuse Large B-cell Lymphoma
    • (no location specified)
    Mar 23, 2023

    Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)

    Not yet recruiting
    • Focal Segmental Glomerulosclerosis
    • Metformin + Standard of Care
    • Placebo + Standard of Care
    • (no location specified)
    Oct 13, 2023

    Relapsing Remitting Multiple Sclerosis Trial in Worldwide (, orelabrutinib)

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • Ormond Beach, Florida
    • +41 more
    Jan 28, 2022